Increase in exhaled nitric oxide and protective role of the nitric oxide system in experimental pulmonary embolism

被引:10
|
作者
Nilsson, K. F.
Gustafsson, L. E.
Adding, L. C.
Linnarsson, D.
Agvald, P.
机构
[1] Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden
[2] Karolinska Inst, Ctr Allerg Res, S-17177 Stockholm, Sweden
关键词
nitric oxide; pulmonary embolism; cardiovascular system; lung diseases; nitric oxide synthase; respiratory system;
D O I
10.1038/sj.bjp.0707001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and purpose: Pulmonary embolism (PE) represents a real diagnostic challenge. PE is associated with pulmonary hypertension due to pulmonary vascular obstruction and vasoconstriction. We recently reported that pulmonary gas embolism transiently increases exhaled nitric oxide (FENO), but it is not known whether solid emboli may alter FENO, and whether an intact endogenous NO synthesis has a beneficial effect in experimental solid pulmonary embolism. Experimental approach: We used anaesthetised and ventilated rabbits in these experiments. To mimic PE, a single intravenous infusion of homogenized autologous skeletal muscle tissue (MPE) was given to rabbits with intact NO production (MPE of 60, 15, or 7.5 mg kg(-1); group 1) and to another group (group 2) with inhibited NO synthesis (L-NAME 30 mg kg(-1); MPE of 7.5, 15 or 30 mg kg(-1)). Key results: In group 1, after MPE, FENO increased rapidly and dose-dependently and FENO was still significantly elevated after 60 min with the two highest emboli doses. All these animals survived more than 60 min after embolization. In group 2, MPE of 7.5, 15 and 30 mg kg(-1), in combination with NO synthesis inhibition, resulted in 67%, 50% and 25% survival at 60 min respectively, representing a statistically significant decrease in survival. Cardiovascular and blood-gas changes after MPE were intensified by pre-treatment with NO synthesis inhibitor. Conclusions and implications: We conclude that solid PE causes a sustained, dose-dependent increase in FENO, giving FENO a diagnostic potential in PE. Furthermore, intact NO production appears critical for tolerance to acute PE.
引用
收藏
页码:494 / 501
页数:8
相关论文
共 50 条
  • [41] Exhaled Nitric Oxide in COPD
    Bikov, Andras
    Meszaros, Martina
    Lazar, Zsofia
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2019, 15 (02) : 71 - 78
  • [42] Exhaled nitric oxide and atopy
    Gratziou, C
    DISEASE MARKERS IN EXHALED BREATH: BASIC MECHANISMS AND CLINICAL APPLICATIONS, 2002, 346 : 191 - 195
  • [43] Caffeine and exhaled nitric oxide
    Thomas, PS
    Yates, DH
    Bruce, C
    THORAX, 2003, 58 (03) : 281 - 281
  • [44] Exhaled nitric oxide and atherosclerosis
    Salonen, Iiris
    Huttunen, Kati
    Hirvonen, Maija-Riitta
    Dufva, Juhani
    Groundstroem, Kaj
    Dufva, Hilkka
    Salonen, Raimo O.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2012, 42 (08) : 873 - 880
  • [45] Exhaled nitric oxide in sarcoidosis
    Wilsher, ML
    Fergusson, W
    Milne, D
    Wells, AU
    THORAX, 2005, 60 (11) : 967 - 970
  • [46] Inhaled and exhaled nitric oxide
    Thébaud, B
    Arnal, JF
    Mercier, JC
    Dinh-Xuan, AT
    CELLULAR AND MOLECULAR LIFE SCIENCES, 1999, 55 (8-9) : 1103 - 1112
  • [47] Perspectives on exhaled nitric oxide
    Ricciardolo, Fabio L. M.
    Silkoff, Philip E.
    JOURNAL OF BREATH RESEARCH, 2017, 11 (04)
  • [48] Exhaled Nitric Oxide An Update
    Hoyte, Flavia C. L.
    Gross, Lara M.
    Katial, Rohit K.
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2018, 38 (04) : 573 - +
  • [49] Exhaled nitric oxide and gender
    Olin, Anna-Carin
    Bake, Bjorn
    Toren, Kjell
    CHEST, 2007, 132 (04) : 1410 - 1410
  • [50] Physiology of exhaled nitric oxide
    Adding, LC
    Gustafsson, LE
    DISEASE MARKERS IN EXHALED BREATH: BASIC MECHANISMS AND CLINICAL APPLICATIONS, 2002, 346 : 35 - 48